Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 4446 (MIR4446) is a human microRNA gene encoding a short (20–24 nt) non-coding RNA that belongs to the microRNA (miRNA) class[1]. MiRNAs are produced from capped and polyadenylated primary transcripts, processed by Drosha and Dicer ribonucleases, and loaded into the RNA-induced silencing complex (RISC) for regulation of gene expression in multicellular organisms. The mature miRNA guides RISC to target mRNAs by imperfect base pairing, leading to inhibition of translation or destabilization of the target mRNA[1][3][4]. MIR4446 has been associated with epilepsy[1], but no direct links to drug interactions or established therapeutic targeting have been described. Like other microRNAs, MIR4446 may serve as a potential biomarker due to the stability and detectability of miRNAs in biofluids, but no specific biomarker applications have been established for this gene[3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 4446 (MIR4446).